Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: We should have enough cash in our coffers - Ads

Nope. But my target would be a relatively small (manageable), promising company with synergistic/familiar tech (and patents) listed on the NYSE that's carrying a bunch of year-over-year tax losses that we could assume (to offset our tax liabilities).

Hopefully a CPA can help here in my thought process (my 30 year old AA in Accounting is useless! LOL). Say we find a candidate as above, and they have $100M in "useable" tax losses on the books and we can buy them out for $40M. Wouldn't the acquisition be essentially "free" to us (assuming we could immediately use up those carried over tax losses)?

And this could maybe be done involving multiple candidates (cum the numbers, but only one need be so listed).

Now, I don't KNOW if such a candidate(s) exists, or if this scenario could play out (help!). But it would be a beautiful thing if it could! Add assets and a possible alternate revenue stream for ultimately no money out. Yowza! The power of CA$H in a world with a "difficult" credit market!

As yesterday (the P/E basis thing - after tax earnings number is used), my corporate tax and accounting knowledge is lacking.

But I will say this: what the headline will read in the/my anticipated PR with the 10Q is "PTSC Reports Record Revenues of $XXX Million for its Third Quarter". That'll be the grabber, IMO. And interest will be further grabbed if they include language like "To date, PTSC, in its alliance with TPL, have secured licenses with 4X corporations around the globe of the 5XX companies they placed on notice for probable infringement of their jointly owned MMP patent portfolio". Both of these things could and should be in the PR, IMO. And hopefully that "5XX" number will be "6XX", "7XX" or higher!

Okay, somebody pop my bubble!

'Cuz I KNOW nuttin'!

SGE

Share
New Message
Please login to post a reply